SARS-CoV-2 genomic analyses in cancer patients reveal elevated intrahost genetic diversity.
Ontology highlight
ABSTRACT: Numerous factors have been identified to influence susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and disease severity. Cancer patients are more prone to clinically evolve to more severe COVID-19 conditions, but the determinants of such a more severe outcome remain largely unknown. We have determined the full-length SARS-CoV-2 genomic sequences of cancer patients and healthcare workers (non-cancer controls) by deep sequencing and investigated the within-host viral population of each infection, quantifying intrahost genetic diversity. Naso- and oropharyngeal SARS-CoV-2+ swabs from 57 cancer patients and 14 healthcare workers from the Brazilian National Cancer Institute were collected in April to May 2020. Complete genome amplification usi
SUBMITTER: Siqueira JD
PROVIDER: S-EPMC7928633 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA